The XbnAb Cohort: 304 people with broadly neutralizing antibody activity to HIV-1
Pasin, C.; Rusert, P.; Schmidt, D.; Schanz, M.; Friedrich, N.; Abela, I. A.; Kusejko, K.; Niklaus, C.; Sickmann, M.; Weber, J.; Huber, M.; Manrique, A.; Rauch, A.; Calmy, A.; Cavassini, M.; Stöckle, M.; Notter, J.; Bernasconi, E.; Braun, D. L.; Günthard, H. F.; Kouyos, R. D.; Trkola, A.; the Swiss HIV Cohort Study,
Show abstract
Broadly neutralizing antibodies (bnAbs) recognizing a diversity of HIV-1 strains are widely thought to be essential for an HIV-1 vaccine. Extensive knowledge on bnAbs has been gained from studying natural HIV infection by following bnAb evolution in individual people with HIV (PWH). However, it remains essential to increase knowledge of bnAb responses in large PWH cohorts to assess the feasibility of inducing bnAb activity by vaccination. To allow a systematic analysis, we created the XbnAb cohort, a large bnAb-inducer cohort selected by screening plasma of PWH enrolled in the Swiss HIV Cohort Study (SHCS) and the Zurich Primary HIV Infection Study (ZPHI). The XbnAb cohort represents a retrospective, biobank-based cohort comprising data of 304 PWH who developed bnAb activity during HIV-1 infection. Here, we report on the characteristics of the XbnAb cohort and its potential for HIV vaccine research.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- In-depth single-cell analysis of translation-competent HIV-1 reservoirs identifies cellular sources of plasma viremia 96%
- Unveiling novel conserved HIV-1 open reading frames encoding T cell antigens using ribosome profiling. 95%
- Resistance of Omicron subvariants BA.2.75.2, BA.4.6 and BQ.1.1 to neutralizing antibodies 94%
Similar papers in this journal
- Transmission of highly virulent CXCR4 tropic HIV-1 through the mucosal route in an individual with a wild-type CCR5 genotype 94%
- Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2 93%
- SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern 93%
Similar papers in this journal
- B cell repertoire sequencing of HIV-1 pediatric elite-neutralizers identifies multiple broadly neutralizing antibody clonotypes 95%
- Deep sequencing of B cell receptor repertoires from COVID-19 patients reveals strong convergent immune signatures 93%
- Contrasting inflammatory signatures in peripheral blood and bronchoalveolar cells reveal compartment-specific effects of HIV infection. 92%
Similar papers in this journal
- Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4 and BA.5 in patients receiving monoclonal antibodies 94%
- Antibody escape drives emergence of diverse spike haplotypes resembling variants of concern in persistent SARS-CoV-2 infections 93%
- COVID-19 convalescents exhibit deficient humoral and T cell responses to variant of concern Spike antigens at 12 month post-infection 93%
Similar papers in this journal
- Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses 94%
- Assessing bnAb potency in the context of HIV-1 Envelope conformational plasticity 94%
- Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.